Stay up-to-date on news that highlights our innovative clinical trials, our Brain Tumor Center team members and updates on our latest research.
Brain tumors:Fighting with targeted tools
Whether malignant or benign, a brain tumor is life-altering. Malignant tumors can spread and become deadly.
Device for noninvasive brain biopsies via blood draw moves closer to market approval
FDA grants WashU-based technology ‘Breakthrough Device’ designation
Predicting survival in glioblastoma with multimodal neuroimaging and machine learning
The ability to predict survival before treatment in GBM patients would lead to improved disease management, clinical trial enrollment, and patient care.
Noninvasive, ultrasound-based brain biopsy is feasible, safe in people
Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases
WashU Neurosurgery welcomes back Dr. Bhuvic Patel
Brain tumor neurosurgeon is returning to his WashU roots.
A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma
The primary objective of this pilot phase Ib study was to validate the on-target effect of tadalafil on inhibiting MDSCs in peripheral blood and its safety when combined with chemoradiotherapy in GBM patients.
Two new researchers join Brain Tumor Center
Rui Tang, PhD and Yang (Eric) Li, PhD, have joined the Brain Tumor Center as assistant research professors.
Brain Tumor Center welcomes new surgeon
Dimitrios Mathios, MD, a brain tumor neurosurgeon from the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, has been named to the WashU Neurosurgery faculty as an assistant professor.
Patients with brain cancer may benefit from treatment to boost white blood cells
Blocking immune suppressor cells in mice with glioblastoma improved survival
St. Louis Blues Fight Cancer (Part 1)
Brain Tumor Center Director Dr. Albert Kim is interviewed about the advantage of care at Siteman Cancer Center.
Brain Tumor Center is Hiring
Does your research focus on fundamental brain tumor biology, immunology or genetics? Or on translational sciences to develop next generation (nano)therapies and device technologies? We want to hear from you. Consider applying for tenure track faculty positions in the WashU BTC.
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
Identifying high-risk patients could improve cancer care.
Kim named inaugural Danforth WashU Physician Scientist Scholar
Neurosurgeon Albert H. Kim is nationally recognized expert on brain tumors.
Stegh named Brain Tumor Center research director
Alexander H. Stegh, PhD, a leading brain cancer scientist, has been named research director of the Brain Tumor Center at Siteman Cancer Center
New Brain Tumor Center at Siteman Cancer Center
The Center’s multidisciplinary approach has already led to several ground-breaking clinical trials, offered at Siteman Cancer Center, including immunotherapy, genomics-based precision medicine, and laser technology to kill tumors from the inside out.
Brain Tumor Center established at Siteman Cancer Center
Neurosurgeon and scientist Albert H. Kim appointed director